Culture

Identifying "ugly ducklings" to catch skin cancer earlier

Melanoma is by far the deadliest form of skin cancer, killing more than 7,000 people in the United States in 2019 alone. Early detection of the disease dramatically reduces the risk of death and the costs of treatment, but widespread melanoma screening is not currently feasible. There are about 12,000 practicing dermatologists in the US, and they would each need to see 27,416 patients per year to screen the entire population for suspicious pigmented lesions (SPLs) that can indicate cancer.

Computer-aided diagnosis (CAD) systems have been developed in recent years to try to solve this problem by analyzing images of skin lesions and automatically identifying SPLs, but so far have failed to meaningfully impact melanoma diagnosis. These CAD algorithms are trained to evaluate each skin lesion individually for suspicious features, but dermatologists compare multiple lesions from an individual patient to determine whether they are cancerous - a method commonly called the "ugly duckling" criteria. No CAD systems in dermatology, to date, have been designed to replicate this diagnosis process.

Now, that oversight has been corrected thanks to a new CAD system for skin lesions based on convolutional deep neural networks (CDNNs) developed by researchers at the Wyss Institute for Biologically Inspired Engineering at Harvard University and the Massachusetts Institute of Technology (MIT). The new system successfully distinguished SPLs from non-suspicious lesions in photos of patients' skin with ~90% accuracy, and for the first time established an "ugly duckling" metric capable of matching the consensus of three dermatologists 88% of the time.

"We essentially provide a well-defined mathematical proxy for the deep intuition a dermatologist relies on when determining whether a skin lesion is suspicious enough to warrant closer examination," said the study's first author Luis Soenksen, Ph.D., a Postdoctoral Fellow at the Wyss Institute who is also a Venture Builder at MIT. "This innovation allows photos of patients' skin to be quickly analyzed to identify lesions that should be evaluated by a dermatologist, allowing effective screening for melanoma at the population level."

The technology is described in Science Translational Medicine, and the CDNN's source code is openly available on GitHub.

Bringing ugly ducklings into focus

Melanoma is personal for Soenksen, who has watched several close friends and family members suffer from the disease. "It amazed me that people can die from melanoma simply because primary care doctors and patients currently don't have the tools to find the "odd" ones efficiently. I decided to take on that problem by leveraging many of the techniques I learned from my work in artificial intelligence at the Wyss and MIT," he said.

Soenksen and his collaborators discovered that all the existing CAD systems created for identifying SPLs only analyzed lesions individually, completely omitting the ugly duckling criteria that dermatologists use to compare several of a patient's moles during an exam. So they decided to build their own.

To ensure that their system could be used by people without specialized dermatology training, the team created a database of more than 33,000 "wide field" images of patients' skin that included backgrounds and other non-skin objects, so that the CDNN would be able to use photos taken from consumer-grade cameras for diagnosis. The images contained both SPLs and non-suspicious skin lesions that were labeled and confirmed by a consensus of three board-certified dermatologists. After training on the database and subsequent refinement and testing, the system was able to distinguish between suspicious from non-suspicious lesions with 90.3% sensitivity and 89.9% specificity, improving upon previously published systems.

But this baseline system was still analyzing the features of individual lesions, rather than features across multiple lesions as dermatologists do. To add the ugly duckling criteria into their model, the team used the extracted features in a secondary stage to create a 3D "map" of all of the lesions in a given image, and calculated how far away from "typical" each lesion's features were. The more "odd" a given lesion was compared to the others in an image, the further away it was from the center of the 3D space. This distance is the first quantifiable definition of the ugly duckling criteria, and serves as a gateway to leveraging deep learning networks to overcome the challenging and time-consuming task of identifying and scrutinizing the differences between all the pigmented lesions in a single patient.

Deep learning vs. dermatologists

Their DCNN still had to pass one final test: performing as well as living, breathing dermatologists at the task of identifying SPLs from images of patients' skin. Three dermatologists examined 135 wide-field photos from 68 patients, and assigned each lesion an "oddness" score that indicated how concerning it looked. The same images were analyzed and scored by the algorithm. When the assessments were compared, the researchers found that the algorithm agreed with the dermatologists' consensus 88% of the time, and with the individual dermatologists 86% of the time.

"This high level of consensus between artificial intelligence and human clinicians is an important advance in this field, because dermatologists' agreement with each other is typically very high, around 90%," said co-author Jim Collins, Ph.D., a Core Faculty member of the Wyss Institute and co-leader of its Predictive Bioanalytics Initiative who is also the Termeer Professor of Medical Engineering and Science at MIT. "Essentially, we've been able to achieve dermatologist-level accuracy in diagnosing potential skin cancer lesions from images that can be taken by anybody with a smartphone, which opens up huge potential for finding and treating melanoma earlier."

Recognizing that such a technology should be made available to as many people as possible for maximum benefit, the team has made their algorithm open-source on GitHub. They hope to partner with medical centers to launch clinical trials further demonstrating their system's efficacy, and with industry to turn it into a product that could be used by primary care providers around the world. They also recognize that in order to be universally helpful, their algorithm needs to be able to function equally well across the full spectrum of human skin tones, which they plan to incorporate into future development.

"Allowing our scientists to purse their passions and visions is key to the success of the Wyss Institute, and it's wonderful to see this advance that can impact all of us in such a meaningful way emerge from a collaboration with our newly formed Predictive Bioanalytics Initiative," said Wyss Founding Director Don Ingber, M.D., Ph.D., who is also the Judah Folkman Professor of Vascular Biology at Harvard Medical School and Boston Children's Hospital, and Professor of Bioengineering at the Harvard John A. Paulson School of Engineering and Applied Sciences.

Credit: 
Wyss Institute for Biologically Inspired Engineering at Harvard

Modeling a better catalyst for PIBSAs

Polyisobutenyl succinic anhydrides (PIBSAs) are important for the auto industry because of their wide use in lubricant and fuel formulations. Their synthesis, however, requires high temperatures and, therefore, higher cost.

Adding a Lewis acid--a substance that can accept a pair of electrons--as a catalyst makes the PIBSA formation more efficient. But which Lewis acid? Despite the importance of PIBSAs in the industrial space, an easy way to screen these catalysts and predict their performance hasn't yet been developed.

New research led by the Computer-Aided Nano and Energy Lab (CANELa) at the University of Pittsburgh Swanson School of Engineering, in collaboration with the Lubrizol Corporation, addresses this problem by revealing the detailed mechanism of the Lewis acid-catalyzed reaction using computational modeling. The work, recently featured on the cover of the journal Industrial & Engineering Chemistry Research, builds a deeper understanding of the catalytic activity and creates a foundation for computationally screening catalysts in the future.

"PIBSAs are commonly synthesized through the reaction between maleic anhydride and polyisobutene. Adding Lewis acids makes the reaction faster and reduces the energy input required for PIBSA formation," explained Giannis Mpourmpakis, the Bicentennial Alumni Faculty Fellow and associate professor of chemical and petroleum engineering at Pitt. "But the reaction mechanism has not been well understood, and there are not many examples of this reaction in the literature. Our work helps to explain the way the reaction happens and identifies Lewis acids that will work best."

This new foundational information will aid in the discovery of Lewis acid catalysts for industrial chemical production at a faster rate and reduced cost.

"The alliance between the University of Pittsburgh and Lubrizol has been instrumental in demonstrating how Academia and the Chemical Process Industry can work together to produce commercially relevant results," said Glenn Cormack, Global Process Innovation Manager at The Lubrizol Corporation. "Combining the knowledge and expertise of the Swanson School of Engineering and The Lubrizol Corporation allows both parties access to some of the best available computational and experimental techniques when exploring new challenges."

The research is one of many collaborations between Pitt and the Lubrizol Corporation, an Ohio-based specialty chemical provider for transportation, industrial and consumer markets. The alliance with Lubrizol, now in its seventh year, provides students with hands-on opportunities to experience how the knowledge and skills they're developing are used in the chemical industry. At the same time, students gain world-ready knowledge how Pitt's research helps improve Lubrizol's processes and products.

"Over the last few years, our partnership with Lubrizol has led to new, innovative ways for Lubrizol to make products and rethink their manufacturing processes," said Steven Little, William Kepler Whiteford Endowed Professor and chair of the Department of Chemical and Petroleum Engineering. "We learn a tremendous amount from them as well, and all of these publications are evidence of an alliance that continues to grow."

The paper, "Computational Screening of Lewis Acid Catalysts for the Ene Reaction between Maleic Anhydride and Polyisobutylene," (DOI: 10.1021/acs.iecr.0c04860 ) was published in the ACS journal I&EC Research. It was authored by Cristian Morales-Rivera and Giannis Mpourmpakis at Pitt and Nico Proust and James Burrington at the Lubrizol Corporation.

Credit: 
University of Pittsburgh

Study: Screen surgery patients for frailty

image: Paula K. Shireman, MD, MS, MBA, of the Long School of Medicine at UT Health San Antonio, coauthored a study that shows surgeons across nine specialties should screen patients for frailty prior to procedures.

Image: 
The University of Texas Health Science Center at San Antonio

SAN ANTONIO -- Patients should be assessed for frailty before having many types of surgery, even if the surgery is considered low risk, a review of two national patient databases shows.

Frailty is a clinical syndrome marked by slow walking speed, weak grip, poor balance, exhaustion and low physical activity. It is an important risk factor for death after surgery, although the association between frailty and mortality across surgical specialties is not well understood.

The study, conducted by faculty at multiple institutions including The University of Texas Health Science Center at San Antonio (UT Health San Antonio), mined patient data from the Veterans Affairs (VA) Surgical Quality Improvement Program and the American College of Surgeons (ACS) National Surgical Quality Improvement Program.

"In previous research, we introduced the concept of an Operative Stress Score to assess the impact of frailty on mortality after surgery," said Paula K. Shireman, MD, MS, MBA, professor of surgery at UT Health San Antonio. She is a vascular surgeon in the university's Joe R. and Teresa Lozano Long School of Medicine and the South Texas Veterans Health Care System.

"In that first study, which examined only VA data, we showed that even patients undergoing low-risk procedures had very high post-operative mortality," Dr. Shireman said.

The question remained: Because frailty screening takes effort and clinics are busy, are there specialties that shouldn't do it because they perform mainly low-risk procedures in patients who are at low risk? In these specialties, does the effort of screening outweigh the benefit?

The newest research, published in JAMA Surgery, assigned Operative Stress Scores (OSS) to cases performed in nine noncardiac specialties including vascular surgery, orthopaedic surgery, neurosurgery, gynecologic surgery, urologic surgery, and ear, nose and throat surgery.

"This time, instead of looking at all cases broadly, we characterized different specialties as high risk or low risk," Dr. Shireman said. "For example, most of the procedures done by urologic surgeons are relatively low risk. Vascular and thoracic surgeons, on the other hand, perform many high-risk procedures."

Operative Stress Scores categorized procedures as low (1-2), moderate (3) and high (4-5) stress. Specialties were categorized by case mix as predominantly low intensity, moderate intensity or high intensity. "Basically, did they do more OSS-1s or did they do more OSS-5s?" Dr. Shireman said.

The study examined 30-day postoperative mortality in the VA case records and 30-day and 180-day mortality after surgery in the ACS registry. 2.3 million patient records are in the American College of Surgeons database and 426,000 in the VA database. 56% of the patients in the ACS registry were women, while 93% of the patients in the VA registry were men. All patients were 18 or older.

The key finding: "Frailty was a consistent, independent risk factor for 30- and 180-day mortality across all specialties," the authors wrote.

"Based upon all of this, the results showed that frailty is prevalent enough that it should be screened in all different surgical specialties, regardless of the case mix," Dr. Shireman said.

Cardiac specialties were not included. The VA has a separate registry for cardiac procedures versus all other surgeries, Dr. Shireman said. The researchers used the all-other-surgeries VA registry.

Credit: 
University of Texas Health Science Center at San Antonio

Do sweat it! Wearable microfluidic sensor to measure lactate concentration in real time

image: It's important to use non-irritating materials in the design of wearable sensors that are used for quantifying lactate levels during exercise

Image: 
Tokyo University of Science

With the seemingly unstoppable advancement in the fields of miniaturization and materials science, all sorts of electronic devices have emerged to help us lead easier and healthier lives. Wearable sensors fall in this category, and they have received much attention lately as useful tools to monitor a person's health in real time. Many such sensors operate by quantifying biomarkers, that is, measurable indicators that reflect one's health condition. Widely used biomarkers are heartrate and body temperature, which can be monitored continuously with relative ease. On the contrary, chemical biomarkers in bodily fluids, such as blood, saliva, and sweat, are more challenging to quantify with wearable sensors.

For instance, lactate, which is produced during the breakdown of glucose in the absence of oxygen in tissues, is an important biomarker present in both blood and sweat that reflects the intensity of physical exercise done as well as the oxygenation of muscles. During exercise, muscles requiring energy can rapidly run out of oxygen and fall back to a different metabolic pathway that provides energy at the 'cost' of accumulating lactate, which causes pain and fatigue. Lactate is then released into the bloodstream and part of it is eliminated through sweat. This means that a wearable chemical sensor could measure the concentration of lactate in sweat to give a real-time picture of the intensity of exercise or the condition of muscles.

Although lactate-measuring wearable sensors have already been proposed, most of them are composed of materials that can cause irritation of the skin. To address this problem, a team of scientists in Japan recently carried out a study to bring us a more comfortable and practical sensor. Their work, which was published in Electrochimica Acta, was led by Associate Professor Isao Shitanda, Mr. Masaya Mitsumoto, and Dr. Noya Loew from the Department of Pure and Applied Chemistry at the Tokyo University of Science, Japan.

The team first focused on the sensing mechanism that they would employ in the sensor. Most lactate biosensors are made by immobilizing lactate oxidase (an enzyme) and an appropriate mediator on an electrode. A chemical reaction involving lactate oxidase, the mediator, and free lactate results in the generation of a measurable current between electrodes--a current that is roughly proportional to the concentration of lactate.

A tricky aspect here is how to immobilize the enzyme and mediator on an electrode. To do this, the scientists employed a method called "electron beam-induced graft polymerization," by which functional molecules were bonded to a carbon-based material that can spontaneously bind to the enzyme. The researchers then turned the material into a liquid ink that can be used to print electrodes. This last part turns out to be an important aspect for the future commercialization of the sensor, as Dr. Shitanda explains, "The fabrication of our sensor is compatible with screen printing, an excellent method for fabricating lightweight, flexible electrodes that can be scaled up for mass production."

With the sensing mechanism complete, the team then designed an appropriate system for collecting sweat and delivering it to the sensor. They achieved this with a microfluidic sweat collection system made out of polydimethylsiloxane (PDMS); it comprised multiple small inlets, an outlet, and a chamber for the sensor in between. "We decided to use PDMS because it is a soft, nonirritating material suitable for our microfluidic sweat collection system, which is to be in direct contact with the skin," comments Mr. Mitsumoto.

The detection limits of the sensor and its operating range for lactate concentrations was confirmed to be suitable for investigating the "lactate threshold"--the point at which aerobic (with oxygen) metabolism turns into anaerobic (without oxygen) metabolism during exercise. Real-time monitoring of this bodily phenomenon is important for several applications, as Dr. Loew remarks, "Monitoring the lactate threshold will help optimize the training of athletes and the exercise routines of rehabilitation patients and the elderly, as well as control the exertion of high-performance workers such as firefighters."

The team is already testing the implementation of this sensor in practical scenarios. With any luck, the progress made in this study will help develop the field of wearable chemical sensors, helping us to keep better track of our bodily processes and maintain better health.

Credit: 
Tokyo University of Science

Edible holograms could someday decorate foods

image: Nanostructures (yellowish-green images; scale bar, 5 μm) were patterned onto dried corn syrup films, producing edible, rainbow-colored holograms (scale bar, 2 mm).

Image: 
Adapted from <i>ACS Nano</i> <b>2021</b>, DOI: 10.1021/acsnano.0c02438

Holograms are everywhere, from driver's licenses to credit cards to product packaging. And now, edible holograms could someday enhance foods. Researchers reporting in ACS Nano have developed a laser-based method to print nanostructured holograms on dried corn syrup films. The edible holograms could also be used to ensure food safety, label a product or indicate sugar content, the researchers say.

Most holograms are imprinted with lasers onto metal surfaces, such as aluminum, but the materials aren't edible. For foods, holograms made with nanoparticles have been proposed, but the tiny particles can generate reactive oxygen species, which might be harmful for people to eat. In a different approach, food scientists have molded edible holograms onto chocolate, but the process only works for certain types of the confection, and a different mold is needed for each hologram design. Bader AlQattan, Haider Butt and colleagues wanted to find a safe, fast and versatile way to pattern edible holograms onto a variety of foods.

To develop their method, the researchers made a solution of corn syrup, vanilla and water and dried it into a thin film. They coated the film with a fine layer of non-toxic black dye. Then, they used a technique called direct laser interference patterning to etch off most of the dye, leaving behind raised, nanoscale lines that formed a diffraction grating. When struck by light, the nanostructure diffracted the light into a rainbow pattern, with different colors appearing at different angles of viewing. The team could control the intensity and range of colors by varying the spacing between lines in the grating or the sugar content of the corn syrup film. Before edible holograms are ready to hit store shelves, however, the researchers want to adapt the method to a food-grade dye that could replace the synthetic black dye used in these pilot experiments.

Credit: 
American Chemical Society

Researchers identify gene implicated in neuroblastoma, a childhood cancer

ROCHESTER, Minn. -- A new study by Mayo Clinic researchers has identified that a chromosome instability gene, USP24, is frequently missing in pediatric patients with neuroblastoma, an aggressive form of childhood cancer. The finding provides important insight into the development of this disease. The study is published in Cancer Research, the journal of the American Association for Cancer Research.

"Neuroblastoma is a highly aggressive cancer that nearly exclusively affects young children," says Paul Galardy, M.D., a pediatric hematologist and oncologist at Mayo Clinic. Despite the use of multiple treatment approaches, Dr. Galardy says many children die of this disease every year.

To identify new therapeutic approaches, Dr. Galardy and his colleagues examined the role of a set of enzymes known as deubiquitinating enzymes (DUB) in this disease. They chose this family of enzymes because they could be targeted using drug therapy.

"Little is known about the role of DUBs in neuroblastoma," says Dr. Galardy. "We used a computational approach to determine the effect of too much or too little of a gene on the outcome of a variety of human cancers to identify DUBs that may play a role in treating neuroblastoma."

Dr. Galardy and his team used this method to identify two genes ? USP24 and USP44 ? with the biggest potential to affect the outcomes of young patients with neuroblastoma. "These genes were the ones most closely implicated as being important for accurate cell division," he says.

Dr. Galardy says that his team found that USP44 plays an important role in cell division and was associated with poor outcomes in lung cancer. Therefore, the team shifted its attention to USP24 to understand how it might contribute to neuroblastoma.

"Little is known about how USP24 functions," says Dr. Galardy. "We observed low levels of USP24 in children with neuroblastoma whose tumors were highly aggressive, leading to early progression or recurrence of the disease." He says low levels of USP24 occur commonly with other markers of aggressive disease, including amplification of the MYCN cancer gene and a loss of a large segment of chromosome 1.

The team also found that USP24 is not simply a marker for aggressive disease. Using genetically engineered mice that lack the USP24 gene, they found that USP24 plays an important role in protecting cells against errors in chromosome distribution that take place during cell division.

"When we compared cells with normal or deleted USP24, and examined the levels of proteins in dividing cells, we found that mice lacking even one of the two copies of USP24 were more prone to developing tumors," says Dr. Galardy. "This helped lead us to our conclusion that USP24 may play a role in ensuring accurate cell division, and that a loss of USP24 in mice leads to tumor formation and may also contribute to the development of aggressive neuroblastoma tumors in children."

Credit: 
Mayo Clinic

Mutation in SARS-CoV-2 spike protein renders virus up to eight times more infectious

A mutation in the spike protein of SARS-CoV-2--one of several genetic mutations in the concerning variants that have emerged in the United Kingdom, South Africa, and Brazil--makes the virus up to eight times more infectious in human cells than the initial virus that originated in China, according to research published in the journal eLife.

The study, led by researchers at New York University, the New York Genome Center, and Mount Sinai, corroborates findings that the D614G mutation makes SARS-CoV-2 more transmissible.

"In the months since we initially conducted this study, the importance of the D614G mutation has grown: the mutation has reached near universal prevalence and is included in all current variants of concern," said Neville Sanjana, assistant professor of biology at NYU, assistant professor of neuroscience and physiology at NYU Grossman School of Medicine, and Core Faculty Member at the New York Genome Center. "Confirming that the mutation leads to more transmissibility may help explain, in part, why the virus has spread so rapidly over the past year."

The D614G mutation in the SARS-CoV-2 spike protein--commonly referred to as the "G variant"--likely emerged in early 2020 and is now is the most prevalent and dominant form of the SARS-CoV-2 virus across the United States and in many countries around the globe. With multiple mutations circulating, researchers have been working to understand the functional significance of these mutations and whether they meaningfully change how infectious or deadly the virus is.

In this study, the researchers introduced a virus with the D614G mutation into human lung, liver, and colon cells. They also introduced the "wild type" version of the coronavirus--the version of the virus without the mutation found early on in the pandemic--into these same cell types for comparison.

They found that the D614G variant increased transduction, or transmissibility, of the virus up to eight-fold as compared to the original virus. The researchers also found that the spike protein mutation made the virus more resistant to being cleaved or split by other proteins. This provides a possible mechanism for the variant's increased ability to infect cells, as the hardier variant resulted in a greater proportion of intact spike protein per virus.

"With our experimental setup we are able to quickly and specifically assess the contribution of G614 and other mutations to the increased spread of SARS-CoV-2," said Tristan Jordan, a postdoctoral scholar in the tenOever Lab at Mount Sinai and co-first author of the study.

"Going into this project we didn't really know if D614G mutation would have any functional effects, as its wide spread could be due to a founder effect, where a variant becomes dominant because a small number of individuals spread it widely by chance. However, our experimental data was pretty unambiguous--the D614G variant infects human cells much more efficiently than the wild type," said Zharko Daniloski, a postdoctoral fellow in Sanjana's lab at NYU and the New York Genome Center and the study's co-first author.

The team's findings join a growing consensus among scientists that the D614G variant is more infectious; this was also demonstrated in studies appearing in Cell by researchers at Los Alamos National Laboratory, in Nature by researchers at the University of North Carolina, and in Science by researchers at the University of Texas. However, it is still unclear whether the variant and its rapid spread have a clinical impact on COVID-19 disease progression, as several studies suggest that the D614G variant is not linked to more severe disease or hospitalization.

The researchers note that findings on the increased transmissibility of the D614G variant may influence COVID-19 vaccine development and, in particular, it may be beneficial for future booster shots to include diverse forms of the spike protein from different circulating variants. The vaccines with emergency use authorization from the FDA, as well as those under development, were created using the original spike sequence; studies are underway to understand how well these vaccines protect against the variants that emerged in the United Kingdom, South Africa, and Brazil, all of which contain the D614G mutation. Recent work from other groups suggests that initial vaccines with the D614 form of spike can protect against the newer G614 form of spike, although more work needs to be done to understand how multiple mutations can interact with each other and impact immune response.

"The research comprising this work is essential to understanding changes in biology that a given viral variant might demonstrate," said co-senior author Benjamin tenOever, Fishberg Professor of Medicine, Icahn Scholar and Professor of Microbiology at the Icahn School of Medicine at Mount Sinai. "We are presently now moving forward with similar studies to study the variants that have arisen in the UK, Brazil, and in South Africa".

Credit: 
New York University

Most teen bullying occurs among peers climbing the social ladder

Teens who bully, harass, or otherwise victimize their peers are not always lashing out in reaction to psychological problems or unhealthy home environments, but are often using aggression strategically to climb their school's social hierarchy, a University of California, Davis, study suggests. These findings point to the reasons why most anti-bullying programs don't work and suggest possible strategies for the future.

"To the extent that this is true, we should expect them to target not vulnerable wallflowers, but their own friends, and friends-of-friends, who are more likely to be their rivals for higher rungs on the social ladder," said Robert Faris, a UC Davis researcher on bullying and author of the paper "With Friends Like These: Aggression From Amity and Equivalence." The paper was published recently in the American Journal of Sociology. Co-authors are sociologists Diane Felmlee at Pennsylvania State University and Cassie McMillan at Northeastern University.

Faris, a professor of sociology, said friends and associates with close ties to one another likely compete for positions within the same clubs, classrooms, sports and dating subgroups, which heightens the risk of conflict and aggression. This paper is the first known to show that those rivals are often their own friends.

This differs from some common theories and definitions of bullying, in which the behavior stems from an imbalance of power and is mainly directed at youths in the lower social strata in school or community environments who possibly have physical, social or psychological vulnerabilities.

The study focuses, instead, on a broader definition of peer aggression -- theorizing that aggression can actually improve the social status of the aggressor.

Using a large, longitudinal social network study of more than 3,000 eighth, ninth and 10th graders in North Carolina over the course of a single school year, the authors found that teens who were friends in the fall were more than three times as likely to bully or victimize each other in the spring of that same school year. This is not merely animosity between former friends who drifted apart: Schoolmates whose friendships ended during the year were three times as likely to bully or victimize each other in the spring, while those whose friendships continued over the school year were over four times as likely to bully those friends, researchers said.

'Frenemy effect'

This "frenemy effect" is not explained by the amount of time friends spent together, Faris explained. Additionally, "structurally equivalent" classmates -- those who are not necessarily friends, but who share many friends in common -- are also more likely to bully or otherwise victimize each other. Compared to schoolmates with no overlapping friendships, those whose friendships are perfectly overlapping are roughly three times more likely to bully each other, and those who share the same bullies or victims are more than twice as likely to bully each other.

Finally, being victimized by friends is particularly painful, and is associated with significant increases in symptoms of depression and anxiety, and significant decreases in school attachment, researchers said.

Real-life case

The paper cites the real-life case of Megan Meier, who hanged herself in 2007 after being bullied by people she thought were her friends -- with the added twist of a mother orchestrating the social media bullying scheme. "The tragedy of Megan Meier highlights more than the limitations of the criminal justice system in addressing complex, often subtle, social problems like bullying," researchers said. The case illustrates the need for research in this area: ... "contrary to the once-prevailing view of bullying as a maladjusted reaction to psychological deficiencies, emotional dysregulation, empathy deficits, or problematic home lives, [the perpetrator of the bullying] is one of millions of adolescents who has harmed a schoolmate for instrumental reasons: to exact retribution, achieve prominence, or vanquish a rival," researchers said. Indeed, the research shows, "the desire for popularity motivates much aggressive behavior."

Few anti-bullying programs work

Additionally, the researchers conclude, few anti-bullying programs work. "The reason for the typically low success rates, we believe, is that aggressive behavior accrues social rewards, and to a degree that leads some to betray their closest friends. Even the most successful prevention programs are unable to alter the aggressive behavior of popular bullies, who use cruelty to gain and maintain status," the authors said. The popularity contests ubiquitous in secondary schools, the authors wrote, encourage peer bullying.

The authors suggest that efforts to support and strengthen adolescent friendships -- such as broadening extracurricular offerings and hosting camps, trainings and retreats -- could help de-emphasize popularity and reduce the "frenemy effect."

Credit: 
University of California - Davis

Research news tip sheet: Story ideas from Johns Hopkins Medicine

image: Research News Tip Sheet: Illustration

Image: 
Johns Hopkins Medicine

PSYCHOLOGICAL HEALTH MAY BE IMPORTANT PREVENTION FACTOR FOR SUDDEN DEATH IN GENETIC HEART DISEASE

Media Contact: Vanessa McMains, Ph.D., vmcmain1@jhmi.edu

Studying mice modeling a human genetic disease that causes irregular heartbeats and can lead to sudden death, Johns Hopkins Medicine researchers have shown that emotional stress seems to promote symptoms of the disease and worsens its progression. The researchers say in their study, published Nov. 24, 2020, in the Journal of Clinical Medicine, that physicians and patients would be wise to focus together on good mental health -- in addition to traditional exercise avoidance -- to keep patients healthy and avoid triggering symptoms.

"There's much evidence that our body and mind are connected so that our psychological states can change the course of disease," says Jacopo Agrimi, Ph.D., a research fellow in the laboratory of Nazareno Paolocci, M.D., Ph.D., associate professor of medicine at the Johns Hopkins University School of Medicine. "Prolonged stress may be like putting fuel on the fire in someone with a chronic disease. So, we need to ensure that we are taking patients' quality of life and psychological wellness into account when managing their disease."

The Johns Hopkins Medicine research study was conceived when the researchers heard anecdotal reports from patients at a seminar held as part of the Johns Hopkins ARVC/D Program.

Arrhythmogenic right ventricular dysplasia (ARVD), also known as arrhythmogenic right ventricular cardiomyopathy (ARVC), is a genetic heart condition and a leading cause of sudden death among young athletes, but it can affect people of all ages and all activity levels. ARVC/D was one of the diseases modeled by the mice in the study.

"Patients often reported that when they heard their defibrillator charging -- which is needed to shock their heart beat back into normal rhythm when disrupted -- they would panic due to past experiences resulting from the pain and discomfort of a defibrillator discharge," says Stephen Chelko, Ph.D., an adjunct assistant professor of medicine at the Johns Hopkins University School of Medicine, as well as an assistant professor of biomedical sciences at Florida State University. "As a result, many people also reported waking up after the shock, hearing the defibrillator recharge and become panicked again, thus creating a viscous cycle."

These patient stories led Chelko and Agrimi to survey patients with these genetic heart diseases about their stress levels during annual clinical follow-ups. They found that those with higher levels of perceived psychosocial stress showed a strong correlation with clinical symptoms as measured by cardiac magnetic resonance imaging or electrocardiogram.

With this knowledge, the researchers then took mice with the second most common genetic mutation for arrhythmogenic cardiomyopathy and put half of the group in stressful situations by exposing them to large, aggressive and bullying mice for weeks.

Almost a third of the mice with the genetic heart condition and placed in the stressful situation died of sudden death compared with the mice with the heart problem in non-stressful situations. The researchers also observed that the stressed mice who remained alive showed more cardiac damage and more rapid disease progression.

"Genetic heart disease is stressful enough without adding psychological stress, with athletes having to give up exercise and participation in sports when they are diagnosed," says Chelko. "We need physicians to help patients navigate the disease and treat the whole condition, including the mental wellness aspect."

Chelko and Agrimi are available for interviews.

JOHNS HOPKINS MEDICINE RESEARCHERS INCREASE UNDERSTANDING OF PEANUT ALLERGIES IN INFANTS

Media Contact: Waun'Shae Blount, wblount1@jhmi.edu

Approximately 2%-3% of Americans are allergic to peanuts. Previous research studies have suggested that introduction of the peanut in the first year of life to infants highly likely to develop a peanut allergy reduces that risk by approximately 80%. However, the best method to safely do this is unclear. Now, a Johns Hopkins Medicine research team has conducted a study that shows which babies are most at risk for peanut allergy and which tests are best for diagnosing them.

The team's findings were reported in two papers in the Jan. 19, 2021, issue of the Journal of Allergy and Clinical Immunology. One paper identifies the likelihood of babies developing a peanut allergy, finding that older infants and ones with moderate-to-severe eczema are most at risk. The other paper compares diagnostic tests for detecting peanut allergy.

"Early introduction of peanut is important to prevent peanut allergy," says Corinne Keet, M.D., Ph.D., associate professor of pediatrics at the Johns Hopkins University School of Medicine. "Current recommendations are that infants with severe eczema be exposed to peanuts early in the first year of life, but also that they get testing before introducing to make sure that they are not already allergic."

"We wanted to know what the real risk for peanut allergy was in this group, and in other potential risk groups, and what tests would be best to use for screening," she explains.

Researchers enrolled 321 children, ages 4 months to 11 months, who had at least one of the following risk factors: a family history of peanut allergy, moderate or severe eczema, or another food allergy other than peanut. The average age of the infants was 7 months and 58% were males. As for racial and ethnic demographics, 74% were identified as white, 8% as Black, 7% as Asian and 12% as multiracial or another racial background. Of the 321, 195 had eczema, 201 had a sibling or parent with a peanut allergy and 59 had a personal history of a food allergy other than peanut. Infants who were enrolled had a skin prick test and blood testing for peanut allergy, and were fed peanuts under observation.

The researchers found that 18% of the infants with moderate to severe eczema were allergic before introducing peanut. They found that risk increased with the severity of eczema, and also increased with each month between 4 months and 11 months of age.

This, say the researchers, suggests that introducing infants with severe eczema to peanuts before they reach the age of 6 months is necessary to effectively prevent the allergy. In contrast, they found that only 1% of the infants who had siblings or parents with a peanut allergy but who did not have eczema had peanut allergy when evaluated. Therefore, the researchers suggest that these infants do not need testing before starting to eat peanut products.

When comparing tests to predict the risk for developing a peanut allergy, the researchers found that the standard tests for peanut allergy -- the peanut-specific IgE (looking for antibodies formed in response to the entire peanut) and the peanut skin prick test -- had high false positive rates. A more recent test that detects IgE specific to one component of the peanut called Ara h 2, rather than the whole peanut, provided a more accurate diagnosis. Current guidelines for diagnosing peanut allergies in infants may need to be modified to reflect these findings, the researchers say.

The researchers conclude that parents of infants with significant eczema should discuss peanut introduction with their pediatricians, with the goal of getting the child exposed to peanut-containing foods before 6 months of age.

Ongoing research by the Johns Hopkins Medicine team involves finding ways to deal with peanut allergies already developed in children, including treatments such as medications and immunotherapy. Clinical trials are planned, including one that will study children with multiple food allergies in order to test methods for treating the allergies all at once.

Keet is available for interviews.

JOHNS HOPKINS CHILDREN'S CENTER PEDIATRIC PATIENT BEATS BLUE BABY SYNDROME

Media Contact: Kim Polyniak, M.A., kpolyni1@jhmi.edu

When Chelsea Presock and David White learned they were expecting, they couldn't have been happier. Halfway into the pregnancy, however, they received shocking news: their little bundle of joy had a heart defect. They were referred to Johns Hopkins Children's Center (JHCC), and their unborn baby girl was diagnosed with a rare congenital heart abnormality called tetralogy of Fallot (TOF), as well as an absent pulmonary valve (the valve that keeps deoxygenated blood on its way to the lungs from backflowing into the heart).

A combination of four heart defects that can lead to lack of oxygen in the blood and reduced blood flow to the lungs, TOF can cause blue baby syndrome, a condition in which a baby's skin can turn blue, often at birth. However, with her absent pulmonary valve, Presock and White's unborn baby was experiencing a compression of the airways that could lead to insufficient levels of oxygen for survival. Fewer than 1% of babies with congenital heart disease have the same diagnosis.

In the early morning hours of Nov. 21, 2019, Presock went into labor. She and White made the three-hour drive from their home on Deal Island on Maryland's Eastern Shore to JHCC to ensure their baby received the critical care she needed. Their daughter, Navy, was welcomed into the world later that same day. When she was born, her lips and feet were blue, along with some of her fingers.

"We didn't know the seriousness of the situation until they rushed me to cut the umbilical cord," White says.

Navy was soon taken to the pediatric cardiac intensive care unit and placed on extracorporeal membrane oxygenation (ECMO), a system that provides heart-lung bypass support outside the baby's body.

"I've only had a moment with this child and thinking about the 'what if' of 'will I have to bury this child?' That was definitely the scariest," Presock recalls.

Though her condition is considered extremely rare, Navy is one of an estimated 1 million children in the United States with a congenital heart defect. According to the U.S. Centers for Disease Control and Prevention, about 40,000 babies each year are born with congenital heart defects.

Navy remained on ECMO for four days after she was born and suffered a mild stroke, which can be a complication from the bypass support system. "It's overwhelming to see all of the lines, the beeping and the medicine, but then you see all this care around her and it makes up for it," Presock says.

After she was removed from ECMO, Navy did well at first but soon she began to face other serious health concerns not related to her heart condition. She developed reflux and was unable to keep food down. She was diagnosed with necrotizing enterocolitis (NEC), a bacterial inflammation that can ultimately destroy the wall of the intestines. Navy was placed on intravenous antibiotics to fight the NEC and underwent abdominal surgery to treat her reflux so that she could eat.

Separate from these problems, Navy also had difficulty breathing. Lung scans showed that one of the lobes of her lungs was larger than the other. Doctors at JHCC performed a lobectomy, taking an enlarged lobe off her right lung.

Little Navy's journey into the world was profoundly challenging, and she remained in the hospital for two and a half months. Finally, she healed enough to go home and get bigger and stronger to prepare for eventual heart surgery. During this time, Navy also was routinely followed by JHCC doctors, including Bret Mettler, M.D., director of pediatric cardiac surgery and co-director of the Blalock-Taussig-Thomas Pediatric and Congenital Heart Center at JHCC.

Eight months later, in September 2020, Navy had open-heart surgery at JHCC to fix her TOF condition and absent pulmonary valve by closing the hole in her heart, moving her pulmonary arteries and making them smaller. The eight-hour operation was successful, and 10 days later, Navy left the hospital.

"Navy was a profoundly sick baby who faced many challenges at such a young age because of her unique heart condition and so many other serious health concerns," Mettler says. "She has come through everything amazingly well, and will be able to live a healthy life."

JHCC doctors continue to follow Navy, who is now 14 months old, because she could need another heart operation later in life. Her parents say that she's thriving, adding that Navy is sassy and loves peanut butter and jelly.

"I want her to be healthy and happy and have a full childhood," White says.

"Navy would not be here without Johns Hopkins Children's Center," Presock says. "The reason God put surgeons here is for people like Navy to be fixed."

Presock, White and Mettler are available for media interviews.

Credit: 
Johns Hopkins Medicine

COVID-19 associated with leukoencephalopathy on brain MRI

image: Axial FLAIR MR image shows T2 prolongation in bilateral middle cerebellar peduncles (arrows). Findings were associated with restricted diffusion and areas of T1 hypointense signal without enhancement or abnormal susceptibility.

Image: 
American Roentgen Ray Society (ARRS), American Journal of Roentgenology (AJR)

Leesburg, VA, February 17, 2021--According to an open-access article in ARRS' American Journal of Roentgenology (AJR), COVID-19-related disseminated leukoencephalopathy (CRDL) represents an important--albeit uncommon--differential consideration in patients with neurologic manifestations of coronavirus disease (COVID-19).

"Increasingly," wrote Colbey W. Freeman and colleagues from the University of Pennsylvania, "effects of COVID-19 on the brain are being reported, including acute necrotizing encephalopathy, infarcts, microhemorrhage, acute disseminated encephalomyelitis, and leukoencephalopathy."

Among the 2,820 patients with COVID-19 admitted to the authors' institution between March 1 and June 18, 2020, 59 (2.1%) underwent brain MRI. Three (5.1%) had known white matter lesions from multiple sclerosis, 23 (39.0%) had white matter lesions of small vessel ischemic disease, six (10.2%) had acute infarcts, four (6.8%) had subacute infarcts, four (6.8%) had chronic infarcts, one (1.7%) had abnormal basal ganglia signal from hypoxemia, two (3.4%) had microhemorrhage in association with chronic infarcts, and two (3.4%) had microhemorrhage associated with acute or subacute infarcts.

Six patients (10.2%; four women, two men; age range, 41-86 years) had neuroimaging findings suggestive of CRDL--"characterized by extensive confluent or multifocal white matter lesions (with characteristics and locations atypical for other causes), microhemorrhages, diffusion restriction, and enhancement," Freeman et al. explained. Hypertension (4/6, 66.7%) and type 2 diabetes mellitus (3/6, 50.0%) were common comorbidities.

Reiterating that no established criteria exist for defining CRDL, "our patients had white matter lesions atypical for other causes," as well as "involvement of the bilateral middle cerebellar peduncles and corpus callosum," the authors of this AJR article concluded.

Credit: 
American Roentgen Ray Society

Breeding better seeds: Healthy food for more people

image: Researchers used genetic engineering to create a type of cotton seed without a substance that is toxic to humans. Now humans can eat these cotton seeds, which are a great source of protein and fiber.

Image: 
Beth Luedeker

Your morning cereal or oatmeal. The bread on your sandwich. The corn chips for your snack, and the cookies for dessert. Not one would be possible with the humblest of ingredients: the seed.

Seeds such as wheat, rice and corn directly provide about 70% of the calories eaten by people every day. And they ultimately provide nearly every morsel of food, either by providing feed for livestock or by being grown into fruits and vegetables. It's no overstatement to say that without seeds, civilization would be impossible.

But seeds need our help. They are under stress from climate change, and under pressure to feed a growing population.

Scores of dedicated scientists spend their careers working to improve seeds. They are using the latest scientific advances to make seeds larger, more nutritious, and more resilient to stress.

Rodomiro Ortiz studies how plant breeding can help meet these goals. His research was recently published in Crop Science, a journal of the Crop Science Society of America.

As the science behind seed improvements, plant breeding is the foundation for ensuring agriculture meets humanity's needs.

"The seeds generated from plant breeding have desired traits that allow increases in productivity, reduce human malnutrition, improve genetic diversity in ecosystems, and ensure sustainable food production under the specter of global warming," says Ortiz.

Classic plant breeding doesn't add in extra DNA like genetic engineering does. Instead, plant breeders cross plants that each have uniquely strong features to create a new plant with several beneficial traits. The same process has been used by farmers and scientists for thousands of years to make better crops.

But today, plant breeders have access to more information and more tools than ever. For example, the widespread use of DNA sequencing gives plant breeders huge troves of data about useful genes. By figuring out which genes give rise to which useful traits, plant breeders can develop new varieties of crops much more quickly.

"Genome-derived knowledge of seed biology can enhance crop productivity, to improve food and nutritional supply through plant breeding," says Ortiz.

But genes are only one piece of the puzzle. Scientists like Ortiz need to know how the plant grows and what it looks like. In the past, scientists might have been able to easily look and tell that one plant had, for example, larger seeds. But today, improving seeds requires ever greater detail.

Enter phenotyping, the science of measurement. A plant's phenotype is its entire expression of its genes in its environment. The height and color of the plant. Its seeds' weight and shape. Its tendency to resist or succumb to disease -- these are all the phenotype.

Capturing this information is time intensive. Some of these traits are impossible for humans to even see. And seeds in particular are so small, measuring them by hand is unrealistic. Technology comes to the rescue.

"Phenotyping seed traits is a major bottleneck to systematic analysis of seed variation," says Ortiz. "Advances in digital imaging technology can automatically measure a variety of shape parameters using high resolution images of seeds."

With these tools in hand, plant breeders can improve seeds and develop new crop varieties faster than ever. Ortiz envisions making seeds larger, so each one has more calories to feed people. Larger seeds can also help the next generation of crops quickly grow in the fields, ready to produce a big yield. And plant breeders are trying to make seed proteins more nutritious or the fats inside seeds stable enough to last on grocery store shelves for longer.

Each of those improvements mean stronger seeds, and better food, for more people. So with your next spoonful of chewy oatmeal, consider the humble seed -- and the advanced tech and know-how -- behind every bite.

Credit: 
American Society of Agronomy

Plastic recycling results in rare metals being found in children's toys and food packaging

Some of the planet's rarest metals - used in the manufacture of smartphones and other electrical equipment - are increasingly being found in everyday consumer plastics, according to new research.

Scientists from the University of Plymouth and University of Illinois at Urbana-Champaign tested a range of new and used products including children's toys, office equipment and cosmetic containers.

Through a number of detailed assessments, they examined levels of rare earth elements (REEs) but also quantities of bromine and antimony, used as flame retardants in electrical equipment and a sign of the presence of recycled electronic plastic.

The results showed one or more REEs were found in 24 of the 31 products tested, including items where unregulated recycling is prohibited such as single-use food packaging.

They were most commonly observed in samples containing bromine and antimony at levels insufficient to effect flame retardancy, but also found in plastics where those chemicals weren't present.

Having also been found in beached marine plastics, the study's authors have suggested there is evidence that REEs are ubiquitous and pervasive contaminants of both contemporary and historical consumer and environmental plastics.

The study, published in Science of the Total Environment, is the first to systematically investigate the full suite of REEs in a broad range of consumer plastics.

While they have previously been found in a variety of environments - including ground water, soils and the atmosphere - the study demonstrates the wide REE contamination of the "plastisphere" that does not appear to be related to a single source or activity.

Dr Andrew Turner, Associate Professor (Reader) in Environmental Sciences at the University of Plymouth and the study's lead author, said: "Rare earth elements have a variety of critical applications in modern electronic equipment because of their magnetic, phosphorescent and electrochemical properties. However, they are not deliberately added to plastic to serve any function. So their presence is more likely the result of incidental contamination during the mechanical separation and processing of recoverable components.

"The health impacts arising from chronic exposure to small quantities of these metals are unknown. But they have been found in greater levels in food and tap water and certain medicines, meaning plastics are unlikely to represent a significant vector of exposure to the general population. However, they could signify the presence of other more widely known and better-studied chemical additives and residues that are a cause for concern."

The research is the latest work by Dr Turner examining the presence of toxic substances within everyday consumer products, marine litter and the wider environment.

In May 2018, he showed that hazardous chemicals such as bromine, antimony and lead are finding their way into food-contact items and other everyday products because manufacturers are using recycled electrical equipment as a source of black plastic.

His work was part of a successful application by the University to earn the Queen's Anniversary Prize for Higher and Further Education for its pioneering research on microplastics pollution.

It also builds on previous work at the University, which saw scientists blend a smartphone to demonstrate quantities of rare or so-called 'conflict' elements in each product.

Credit: 
University of Plymouth

Evolution's game of rock-paper-scissors

image: Gregory Lang, an associate professor in the Department of Biological Sciences at Lehigh University, in his lab.

Image: 
Douglas Benedict/Academic Image

If B is better than A, and C is better than B, it follows by the transitive property that C is better than A. And, yet, this is not always the case. Every kid is familiar with the Rock-Paper-Scissors game--the epitome of nontransitivity in which there is no clear hierarchy among the three choices, despite each two-way interaction having a clear winner: Paper beats Rock, Scissors beats Paper, and Rock beats Scissors.

Evolution may be teeming with nontransitive interactions as well. While natural selection - the process by which organisms better adapted to their environments are more likely to survive and pass on their genes - can be observed over shorter time intervals, there is still debate about whether fitness gains accumulate over long evolutionary time scales. In other words, one might expect that successive adaptive events (like the two-way interactions of Rock-Paper-Scissors) would translate into a cumulative increase in fitness, resulting in the very latest generation always being more fit than its all of its genealogical ancestors. However, this turns out to not be true in every case.

The evolutionary process, then, includes what are known as nontransitive interactions, sometimes producing organisms that are less fit than its ancestors. Experimental demonstrations of such nontransitivity, however, have been lacking.

Until now. A group of scientists at Lehigh University led by Gregory Lang, associate professor in the Department of Biological Sciences, has recently provided empirical evidence that evolution can be nontransitive. Lang and his team identify a nontransitive evolutionary sequence through a 1,000-generation yeast evolution experiment. In the experiment, an evolved clone outcompetes a recent ancestor but loses in direct competition with a distant ancestor.

The nontransitivity in this case arose as a result of multilevel selection that involved adaptive changes in both the yeast nuclear genome and the genome of an intracellular RNA virus. The results, which provide experimental evidence that the continuous action of selection can give rise to organisms that are less fit compared to a distant ancestor, are described in an article published in eLife Journal today called "Adaptive evolution of nontransitive fitness in yeast" (DOI: 10.7554/eLife.62238).

This study confronts two common misconceptions about evolution, according to Lang. The first, he says, is that evolution is a linear "march of progress" where each organism along a line of descent is more fit than all those that came before it.

Lang and his colleagues set out to determine how nontransitivity arose along a particular line of genealogical descent. In their 1,000-generation yeast experiment, nontransitivity arose due to adaptation in the yeast nuclear genome combined with the stepwise deterioration of an intracellular virus. Initially the population produced a virally encoded toxin and was immune to the toxin. As the population adapted, it fixed the beneficial nuclear mutations as well as mutations within the intracellular viral population that resulted in loss of toxin production. Over time the more beneficial nuclear mutations fix, and selection in the viral population resulted in a loss of toxin immunity - since the toxin was no longer produced. When placed in competition against its distant ancestor, the 1,000-generation evolved population lost due to the toxin produced by the ancestor.

"Another misconception is that there is a single locus of selection," says Lang. "Multilevel selection--as its name implies--states that selection can act simultaneously on multiple levels of biological organization."

In the context of this experiment, multilevel selection was common, says Lang. "Selection acts across multiple levels of biological organization, from genes within a cell to individuals within a population. Selection at one level can impact fitness at another.

"In fact, when we expanded our study of host-virus genome evolution to additional populations, we found that nearly half of the approximately 140 populations we studied experienced multilevel selection, fixing adaptive mutations in both the nuclear and viral genomes," he adds.

"Laboratory evolution experiments have proven highly effective for studying evolutionary principles, yet this work is the first to document a non-transitive interaction and provide a mechanistic explanation," says co-author Sean W. Buskirk, an assistant professor at West Chester University who collaborated on the research when a postdoctoral student in Lang's lab. "Ultimately, the presence of a virus in the ancestor drastically impacts how the evolved yeast populations compete and interact with one another."

The work of co-author Alecia B. Rokes, at the time an undergraduate biology major at Lehigh, focused on competing two intracellular viruses inside yeast cells in what she terms her very own "virus fight club."

"I worked on competing two viruses within the yeast cells to see if either virus variant had an advantage over the other, thus leading to higher frequency and one virus outcompeting the other," says Rokes, now a graduate student in microbiology at the University of Pittsburgh. "It was amazing to be part of the process of elimination, persistence, and pure curiosity that went into figuring out what was actually going on in these populations."

By showing that nontransitive interactions can arise along a line of genealogical succession, the team's work has broad implications for the scientific community's understanding of evolutionary processes.

"It resolves what evolutionary biologist Stephen Jay Gould referred to as 'the paradox of the first tier,' which is the failure to identify broad patterns of progress over long evolutionary time scales, despite clear evidence of selection acting over successive short time intervals," says Lang. "In addition, it calls into doubt whether true fitness maxima exist and, more broadly, it implies that directionality and progress in evolution may be illusory."

Credit: 
Lehigh University

All the colours of the dingo: not just a yellow dog

image: Pure dingoes come in a range of coat colours, including brindle, black and tan, patchy or sable.

Image: 
Michelle J Photography

There is no coat colour that distinguishes dingoes from dingo-dog hybrids, a study involving UNSW Sydney has found.

The Centre for Ecosystem Science research suggests that animals assumed to be dingo-dog hybrids based on their coat colour and culled may have been pure dingoes.

"We actually found pure dingoes that had a brindle, black and tan, patchy or sable coat colour," Dr Kylie Cairns, a conservation biologist from UNSW Sydney and co-author of the study said.

"So that's showing that really dingoes are much more variable than we think and seeing an animal with an odd coat colour doesn't immediately mean that it's a hybrid.

"Using coat colour to decide what animals should be culled is not a very good idea."

The study follows 2019 research by UNSW and collaborators which found that almost all wild dogs in NSW are dingoes or dingo-dominant hybrids, challenging the widely held view that pure dingoes are virtually extinct in the state.

In Australia, dingoes are typically believed to be ginger in colour, while unusual coat colours such as brindle (black and brown stripes) or sable (ginger with a black stripe along the spine) are widely put forward to be evidence of contemporary domestic dog hybridisation.

But the study, published in the Journal of Zoology, found that while 53 per cent of dingoes have a ginger coat colour, 9 per cent were sable, 11 per cent black and tan, 14 per cent brindle, 5 per cent black, 1 per cent white and 6 per cent were patchy (white with spots of ginger or black).

Researchers from UNSW, University of Sydney and University of Melbourne took part in the study.

They examined the relationship between coat colour and ancestry in wild dingoes by testing the genetic makeup of 1325 wild canids (animals belonging to the Canidae family, such as dingoes, domestic dogs and wolves) across south-eastern NSW.

About a quarter of the samples were dingoes with no evidence of domestic dog ancestry while around three-quarters were dingoes with some domestic dog ancestry.

They found that domestic dogs with no dingo ancestry are rare in the wild, representing less than 1.5 per cent of the population.

There was also no coat colour that could distinguish dingoes with or without dog ancestry from each other, or from domestic dogs.

"The widely held idea is that a dingo is ginger animal with white socks and a white tail tip," Michael Letnic, senior author of the paper and professor in conservation biology and ecosystem restoration at UNSW Science said.

"But a key finding of this work is that coat colour should not be used to assess ancestry in dingoes."

The researchers suggest that other features such as floppy ears or a broad snout shape could be used to identify feral domestic dogs or recent dingo-dog hybrids.

The researchers are planning to use updated genetic techniques to look at dingo ancestry across Australia to uncover the origin of some of the coat colours.

"We want to examine whether these coat colours are ancestral or came from dogs originally but have been present in the population for 100 and 200 years," Dr Cairns said.

"We are curious to see if coat colour is part of the natural selection and adaption in dingoes, or if there are other reasons for these coat colours.

"For example, the black coat colour in wolves came from dogs and is associated with increased immunity and so we want to look to see if there is a similar pattern in dingoes."

Read the study in Journal of Zoology.

Credit: 
University of New South Wales

TB study reveals potential targets to treat and control infection

San Antonio, Texas (February 15, 2020) - Researchers at the Southwest National Primate Research Center (SNPRC) at Texas Biomedical Research Institute (Texas Biomed) may have found a new pathway to treat and control tuberculosis (TB), the disease caused by Mycobacterium tuberculosis (Mtb). Using single-cell RNA sequencing (scRNAseq), a next-generation sequencing technology, scientists were able to further define the mechanisms that lead to TB infection and latency. Co-led by Deepak Kaushal, Ph.D., Director of the SNPRC, this is the first study that used scRNAseq to study TB in macaques in depth. Results from the study were published in Cell Host & Microbe.

"Single-cell RNAseq is a novel approach that has developed in the past three or four years. It's an approach that allows us to look at the immune response more granularly, in higher resolution," Dr. Kaushal explained. "We were able to identify an immune response to Mtb infection in single lung cells as the infection progressed to disease, in some cases, or was controlled in others."

The number of TB related deaths has decreased by 30% globally. However, according to the World Health Organization, 1.4 million people died from TB in 2019; the disease continues to be one of the top communicable diseases plaguing low-income countries. It's one of several diseases negatively impacted by COVID-19 due to the virus's impact on health systems worldwide. TB is primarily spread by a cough or sneeze from someone who is infected with the disease; however, people with latent TB are not contagious. The disease is both preventable and treatable, but latent TB can become active if disrupted by another invading infection, such as Human Immunodeficiency Virus (HIV) and drug resistance continues to be a major impediment.

The study highlighted that plasmacytoid dendritic cells, which sense infection in the body, overproduce Type I interferons. Plasmacytoid dendritic cells are immune cells sent out to stop a bacteria or virus from replicating or causing disease. However, an overproduction of interferons can also cause harm. In this study, scientists observed that the interferon response correlated with disease instead of control. This information is important to scientists developing TB therapeutics and vaccines. Modifications to therapeutic/vaccine formulas may be needed to address interferon signaling.

"When we have a more precise understanding of how an infection develops, that knowledge can lead us to identify new drugs or therapies to treat disease and improve vaccines," Dr. Kaushal said. "Although our findings decreased the gap in knowledge of TB disease and latent infection, there's still more we need to learn."

Credit: 
Texas Biomedical Research Institute